Avalo Therapeutics Inc (AVTX) Insider Trading
- $1,964,351.39
- $2,086,839.98
- March 16, 2026
- Caissa Capital Management Ltd.
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| March 16, 2026 | Insider | 25,492 | $16.15 | Sell | $411,695.80 | |
| Nov. 12, 2024 | Director | 500 | $12.50 | Buy | $6,250.00 | |
| June 26, 2023 | Major Shareholder | 2,746,138 | $0.61 | Sell | $1,675,144.18 | |
| June 20, 2023 | Major Shareholder | 2,000 | $4.14 | Buy | $8,280.00 | |
| June 16, 2023 | Major Shareholder | 3,000 | $3.90 | Buy | $11,700.00 | |
| June 14, 2023 | Major Shareholder | 6,000 | $3.48 | Buy | $20,880.00 | |
| June 12, 2023 | Major Shareholder | 2,149 | $4.34 | Buy | $9,326.66 | |
| June 9, 2023 | CFO | 511 | $3.42 | Buy | $1,747.62 | |
| June 9, 2023 | CEO | 4,000 | $3.42 | Buy | $13,680.00 | |
| May 30, 2023 | Major Shareholder | 671 | $2.87 | Buy | $1,925.77 | |
| May 25, 2023 | Major Shareholder | 2,000 | $2.77 | Buy | $5,540.00 | |
| May 22, 2023 | Major Shareholder | 7,000 | $3.34 | Buy | $23,380.00 | |
| May 18, 2023 | Major Shareholder | 13,121 | $3.29 | Buy | $43,168.09 | |
| May 15, 2023 | Major Shareholder | 1,715 | $2.55 | Buy | $4,373.25 | |
| May 12, 2023 | Major Shareholder | 2,285 | $2.45 | Buy | $5,598.25 | |
| May 8, 2023 | Major Shareholder | 5,000 | $2.62 | Buy | $13,100.00 | |
| May 4, 2023 | Major Shareholder | 15,000 | $2.79 | Buy | $41,850.00 | |
| April 26, 2023 | Major Shareholder | 425 | $2.97 | Buy | $1,262.25 | |
| April 24, 2023 | Major Shareholder | 12,500 | $3.06 | Buy | $38,250.00 | |
| April 20, 2023 | Major Shareholder | 5,000 | $3.08 | Buy | $15,400.00 | |
| April 17, 2023 | Major Shareholder | 15,000 | $2.96 | Buy | $44,400.00 | |
| April 10, 2023 | Major Shareholder | 31,329 | $2.28 | Buy | $71,430.12 | |
| Dec. 9, 2022 | CEO | 2,083 | $4.42 | Buy | $9,206.86 | |
| March 14, 2022 | Director | 100,000 | $0.65 | Buy | $65,000.00 | |
| March 10, 2022 | Director | 26,000 | $0.70 | Buy | $18,200.00 | |
| March 7, 2022 | Director | 325,000 | $0.66 | Buy | $214,500.00 | |
| March 3, 2022 | Director | 50,000 | $0.71 | Buy | $35,500.00 | |
| Feb. 24, 2022 | Director | 100,000 | $0.80 | Buy | $80,000.00 | |
| Feb. 22, 2022 | Director | 83,000 | $0.77 | Buy | $63,910.00 | |
| Feb. 17, 2022 | Director | 150,000 | $0.81 | Buy | $121,500.00 | |
| Jan. 20, 2022 | Director | 12,000 | $0.85 | Buy | $10,200.00 | |
| Jan. 18, 2022 | Director | 206,300 | $0.88 | Buy | $181,544.00 | |
| Jan. 14, 2022 | Director | 85,000 | $0.93 | Buy | $79,050.00 | |
| Jan. 12, 2022 | Director | 57,300 | $1.04 | Buy | $59,592.00 | |
| Jan. 10, 2022 | Director | 491,097 | $0.99 | Buy | $486,186.03 | |
| Jan. 7, 2022 | Director | 137,900 | $1.04 | Buy | $143,416.00 | |
| Dec. 10, 2021 | CFO | 2,231 | $1.57 | Buy | $3,502.67 | |
| Dec. 10, 2021 | Insider | 6,371 | $1.57 | Buy | $10,002.47 | |
| Dec. 10, 2021 | CAO | 955 | $1.57 | Buy | $1,499.35 |
Insiders are both buying and selling Avalo Therapeutics Inc stock.
The insider traders at Avalo Therapeutics Inc are: Caissa Capital Management Ltd., Armistice Capital, Llc, Christopher Ryan Sullivan, Garry Arthur Neil, Schond L Greenway, H Jeffrey Wilkins, June Sherie Almenoff, and Mittie Doyle
The most active insider trader at Avalo Therapeutics Inc is Caissa Capital Management Ltd. with 17 trades.
Armistice Capital, Llc has sold the most Avalo Therapeutics Inc stock with a total value of $3,350,288.36.
Armistice Capital, Llc has bought the most Avalo Therapeutics Inc stock with a total value of $1,623,598.03.
The most recent insider trade for Avalo Therapeutics Inc was on March 16, 2026.
The single biggest insider buy for Avalo Therapeutics Inc was from Armistice Capital, Llc with a total value of $486,186.03 on Jan. 10, 2022.
The single biggest insider sell for Avalo Therapeutics Inc was from Armistice Capital, Llc with a total value of $1,675,144.18 on June 26, 2023.
